These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Health Care Workers' Knowledge, Perceptions, and Behaviors Regarding Antineoplastic Drugs: Survey From British Columbia, Canada. Hon CY; Teschke K; Shen H J Occup Environ Hyg; 2015; 12(10):669-77. PubMed ID: 25897641 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapy in the geriatric population. Green JM; Hacker ED Clin J Oncol Nurs; 2004 Dec; 8(6):591-7. PubMed ID: 15637954 [TBL] [Abstract][Full Text] [Related]
6. Best practices in the management of toxicities related to anti-EGFR agents for metastatic colorectal cancer. Ouwerkerk J; Boers-Doets C Eur J Oncol Nurs; 2010 Sep; 14(4):337-49. PubMed ID: 20580896 [TBL] [Abstract][Full Text] [Related]
7. Intravesical antineoplastic therapy following transurethral resection of bladder tumors: nursing implications from the operating room to discharge. Washburn DJ Clin J Oncol Nurs; 2007 Aug; 11(4):553-9. PubMed ID: 17723968 [TBL] [Abstract][Full Text] [Related]
8. Surgery for cancer patients. Critical care needs. Muehlbauer PM; White RL Crit Care Nurs Clin North Am; 2000 Sep; 12(3):249-67. PubMed ID: 11855231 [TBL] [Abstract][Full Text] [Related]
9. Managing patients through aggressive cancer therapies. ONS News; 2004; 19(9 Suppl):33-4. PubMed ID: 15478577 [TBL] [Abstract][Full Text] [Related]
10. Managing hematologic toxicities in the oncology patient. Montoya L J Infus Nurs; 2007; 30(3):168-72. PubMed ID: 17505218 [TBL] [Abstract][Full Text] [Related]
11. The AIM Higher Initiative: new procedures implemented for assessment, information, and management of chemotherapy toxicities in community oncology clinics. Moore K; Johnson G; Fortner BV; Houts AC Clin J Oncol Nurs; 2008 Apr; 12(2):229-38. PubMed ID: 18390459 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy. Moore MJ; Erlichman C Clin Pharmacokinet; 1987 Oct; 13(4):205-27. PubMed ID: 3311530 [TBL] [Abstract][Full Text] [Related]
13. Update for nurse anesthetists. Anesthetic implications for cancer chemotherapy. Maracic L; Van Nostrand J; Beach D AANA J; 2007 Jun; 75(3):219-26. PubMed ID: 17591304 [TBL] [Abstract][Full Text] [Related]
16. Cerebellar assessment for patients receiving high-dose cytarabine: a standardized approach to nursing assessment and documentation. Brown C Clin J Oncol Nurs; 2010 Jun; 14(3):371-3. PubMed ID: 20529799 [TBL] [Abstract][Full Text] [Related]
17. Bortezomib, a newly approved proteasome inhibitor for the treatment of multiple myeloma: nursing implications. Colson K; Doss DS; Swift R; Tariman J; Thomas TE Clin J Oncol Nurs; 2004 Oct; 8(5):473-80. PubMed ID: 15515281 [TBL] [Abstract][Full Text] [Related]
18. Nursing management of patients with malignant melanoma receiving adjuvant alpha interferon-2b. Kiley KE; Gale DM Clin J Oncol Nurs; 1998 Jan; 2(1):11-6. PubMed ID: 9481251 [TBL] [Abstract][Full Text] [Related]
19. Docetaxel-related side effects and their management. Baker J; Ajani J; Scotté F; Winther D; Martin M; Aapro MS; von Minckwitz G Eur J Oncol Nurs; 2008 Jul; 12(3):253-68. PubMed ID: 18501674 [TBL] [Abstract][Full Text] [Related]
20. Demystifying CINV control in the complex aging patient: assessing the complexities of the aging oncology patient. ONS News; 2004; 19(9 Suppl):5-8. PubMed ID: 15478565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]